NxStage Medical, Inc.  

(Public, NASDAQ:NXTM)   Watch this stock  
Find more results for nxtm
-0.37 (-2.54%)
Real-time:   10:24AM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 14.05 - 16.08
52 week 13.47 - 22.60
Open 15.00
Vol / Avg. 207,671.00/661,939.00
Mkt cap 869.76M
P/E     -
Div/yield     -
EPS -0.24
Shares 64.07M
Beta 0.26
Inst. own 107%
May 4, 2016
Q1 2016 NxStage Medical Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Mar 16, 2016
NxStage Medical Inc at Barclays Global Healthcare Conference - 3:50PM EDT - Add to calendar
Feb 11, 2016
NxStage Medical Inc at Leerink Partners Global Healthcare Conference
Feb 10, 2016
Q4 2015 NxStage Medical Inc Earnings Release
Feb 10, 2016
Q4 2015 NxStage Medical Inc Earnings Call
Dec 1, 2015
NxStage Medical Inc at Piper Jaffray Healthcare Conference
Nov 18, 2015
NxStage Medical Inc at Jefferies Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin -3.12% -4.84%
Operating margin -2.56% -4.35%
EBITD margin - 4.79%
Return on average assets -3.66% -5.27%
Return on average equity -5.62% -8.03%
Employees 3,400 -
CDP Score - -


350 Merrimack St
LAWRENCE, MA 01843-1748
United States - Map
+1-978-6874700 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


NxStage Medical, Inc. is a medical device company. The Company is engaged in the development, manufacturing and marketing of products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. The Company’s products include the System One, Streamline Blood Tubing Sets and AV Fistula and Apheresis Needles. Its primary product, the System One, is a small, portable, easy-to-use hemodialysis system. It is designed to deliver the therapeutic flexibility and clinical benefits associated with traditional dialysis machines in a smaller, portable, easy-to-use form that can be used by healthcare professionals and trained lay users alike in a variety of settings, including patient homes, as well as more traditional care settings such as hospitals and dialysis centers. The Company operates in three reportable business segments: System One, In-Center and Services.

Officers and directors

Robert G. Funari Independent Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Joseph E. Turk Jr. President
Age: 47
Bio & Compensation  - Reuters
Jeffrey H. Burbank Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Matthew W. Towse CPA, Chief Financial Officer, Senior Vice President
Age: 52
Bio & Compensation  - Reuters
Robert S Brown President of NxStage Kidney Care
Age: 56
Bio & Compensation  - Reuters
Winifred L. Swan J.D. Senior Vice President, General Counsel
Age: 50
Bio & Compensation  - Reuters
Daniel A. Giannini CPA, Independent Director
Age: 65
Bio & Compensation  - Reuters
Earl R. Lewis Independent Director
Age: 71
Bio & Compensation  - Reuters
Jean K. Mixer Independent Director
Age: 48
Bio & Compensation  - Reuters
Craig W. Moore Independent Director
Age: 71
Bio & Compensation  - Reuters